China Growth Equity

Baird Capital’s China Growth Equity team invests in smaller, high-growth companies located in China or with substantial operations and growth opportunities in China. We focus on the Healthcare, Technology & Services, and Products sectors.

With more than 15 experienced investment and operating professionals across Asia, our team has a unique ability to drive value in Chinese companies on both a local and global basis. We take a hands-on approach to helping our portfolio companies grow, leveraging our operational resources and global relationship network to build market-leading companies in China.

We invest up to $15 million in private, entrepreneur-owned companies that meet our three basic investment criteria:

Significant China Opportunity – Substantial existing operations in China and a large future growth opportunity
Operates in one of our sectors of focus
Opportunity to add operational and strategic value through our global resources

In addition, our extensive global resources allow us to bring significant value to smaller Chinese companies.